Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy

BACKGROUND: Esophageal cancer patients face a dismal outcome despite tri-modality management and median survival remains 15-18 months. Breast cancer resistance protein (BCRP) is an ATP-dependent efflux protein associated with chemotherapy resistance. The role of BCRP expression in esophageal cancer...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bharthuar, Anubha, Saif Ur Rehman, Sana, Black, Jennifer D., Levea, Charles, Malhotra, Usha, Mashtare, Terry L., Iyer, Renuka
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Pioneer Bioscience Publishing Company 2014
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110489/
https://ncbi.nlm.nih.gov/pubmed/25083297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2014.018
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia